Screener
Ingevity NGVT Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Ingevity in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Ingevity’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:26 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001653477-26-000035
| In millions, except share and par value data | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total Liabilities | 1,611.3 | 1,621.4 |
| Commitments and contingencies (Note 13) | ||
| Equity | ||
| Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2026 and 2025, respectively) | — | — |
| Common stock (par value $0.01 per share; 300,000,000 shares authorized; 44,121,781 and 43,891,710 issued and 34,887,099 and 35,485,876 outstanding at 2026 and 2025, respectively) | 0.4 | 0.4 |
| Additional paid-in capital | 203.4 | 195.7 |
| Retained earnings | 464.7 | 404.9 |
| Accumulated other comprehensive income (loss) | (1.6) | 0.5 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ingevity's preferred stock, shares authorized?
- Ingevity (NGVT) reported preferred stock, shares authorized of $50M in Q1 2026.
- How has Ingevity's preferred stock, shares authorized changed year-over-year?
- Ingevity's preferred stock, shares authorized decreased by 0.0% year-over-year, from $50M to $50M.
- What is the long-term trend for Ingevity's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Ingevity's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $50M to $50M.
Ask your AI about Ingevity's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude